Command Palette

Search for a command to run...

Clinical Trials · NCT05360147

Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Third Military Medical University
Enrollment
30
Start date
Jan 2021
Locations
1 site, China
Primary endpoint
Changes in cognitive function from baseline to 12 weeks
View Liraglutide compound reference